Recap: Trulieve Cannabis Q4 Earnings
Portfolio Pulse from Benzinga Insights
Trulieve Cannabis (OTC:TCNNF) reported Q4 earnings, beating estimated earnings by 25.0% with an EPS of $-0.12 versus an estimate of $-0.16. However, revenue was down $15.00 million from the same period last year. In the previous quarter, the company also beat EPS estimates which led to an 8.0% increase in share price the following day.
February 29, 2024 | 11:15 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Trulieve Cannabis reported a positive earnings surprise of 25.0% for Q4, with an EPS of $-0.12 against an estimate of $-0.16, but experienced a revenue decline of $15 million YoY.
The positive earnings surprise of 25.0% for Trulieve Cannabis is likely to be viewed favorably by investors, potentially leading to a short-term increase in stock price, similar to the previous quarter's reaction. However, the decline in revenue year-over-year could temper some of the positive sentiment, making the overall impact on the stock price positive but with caution.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100